Challenges of Regulation and Risk Assessment of Nanomaterials

More documents

Recommendations

Info

The mission of the JRC-IHCP is to protect the interests and health of the consumer in the framework of EU legislation on chemicals, food, and consumer products by providing scientific and technical support including risk-benefit assessment and analysis of traceability. European Commission Joint Research Centre Institute for Health and Consumer Protection Contact information IHCP Communication Office Address: Via E. Fermi 2749 – 21027 Ispra (VA) - Italy E-mail: jrc-ihcp-communication@ec.europa.eu http://ihcp.jrc.ec.europa.eu/ http://www.jrc.ec.europa.eu/ Legal Notice Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use which might be made of this publication. Europe Direct is a service to help you find answers to your questions about the European Union Freephone number (*): 00 800 6 7 8 9 10 11 (*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed. A great deal of additional information on the European Union is available on the Internet. It can be accessed through the Europa server http://europa.eu/ JRC 67654 Luxembourg: Office for Official Publications of the European Union © European Union, 2011 Reproduction is authorised provided the source is acknowledged Printed in Italy Cover: Participants of the workshop
TABLE OF CONTENTS 1. INTRODUCTION ...........................................................................................4 2. REGULATORY DEVELOPMENTS................................................................5 2.1. Summary record ...................................................................................5 2.2. Abstracts...............................................................................................8 3. REGULATORY IMPLEMENTATION ...........................................................14 3.1. Summary record .................................................................................14 3.2. Abstracts.............................................................................................20 4. CHARACTERISATION AND DETECTION OF NANOMATERIALS ............29 4.1. Summary record .................................................................................29 4.2. Abstracts.............................................................................................31 5. EXPOSURE ASSESSMENT .......................................................................35 5.1. Summary record .................................................................................35 5.2. Abstracts.............................................................................................37 6. ECOTOXICITY AND ENVIRONMENTAL FATE ..........................................40 6.1. Summary record .................................................................................40 6.2. Abstracts.............................................................................................43 7. HUMAN TOXICITY ......................................................................................51 7.1. Summary record .................................................................................51 7.2. Abstracts.............................................................................................53 I. ANNEX I: LIST OF PARTICIPANTS............................................................60 II. ANNEX II: WORKSHOP AGENDA ..............................................................64 3
Page 1: Challenges of Regulation and Risk A
Page 5 and 6: 2. REGULATORY DEVELOPMENTS 2.1. Sum
Page 7 and 8: into risk assessments and risk mana
Page 9 and 10: Nanomaterials in the Regulatory Dev
Page 11 and 12: Guidance on the risk assessment of
Page 13 and 14: Current Progress of activity and ef
Page 15 and 16: of the Sponsorship programme and pr
Page 17 and 18: exposure using new metrics and to d
Page 19 and 20: and risks would increase the probab
Page 21 and 22: OECD Working Party on Manufactured
Page 23 and 24: REACH Implementation Project on Nan
Page 25 and 26: Industry experience with conducting
Page 27 and 28: Health, Safety, and Environment: As
Page 29 and 30: 4. CHARACTERISATION AND DETECTION O
Page 31 and 32: 4.2. Abstracts 31
Page 33 and 34: Primary and secondary characterizat
Page 35 and 36: 5. EXPOSURE ASSESSMENT 5.1. Summary
Page 39 and 40: Application and adaptation of expos
Page 41 and 42: areas. The final remark was that th
Page 45 and 46: Integrating test strategy for ecoto
Page 47 and 48: Ageing and Toxicity of real NM in a
Page 49 and 50: The bioavailability and trophic tra
Page 51 and 52: 7. HUMAN TOXICITY 7.1. Summary reco
Page 53 and 54:
7.2. Abstracts 53
Page 55 and 56:
Variation in acute toxicity for 9 e
Page 57 and 58:
In conclusion, the in vitro hepatoc
Page 59 and 60:
Acknowledgements The editors would
Page 61 and 62:
24 FURUNO Shoko Association (NIA) A
Page 63 and 64:
76 VOM BROCKE Jochen German Federal
Page 65 and 66:
05. NANEX: development of Exposure
Page 68 and 69:
European Commission JRC 67654- Join
Page 70:
The mission of the JRC is to provid
show all

Challenges of Regulation and Risk Assessment of Nanomaterials

Create successful ePaper yourself

Delete template?

Save as template?